Scagliotti, G. V., & Manegold, C. (2012). Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: Subgroup analysis from a randomized phase 3 study. Journal of thoracic oncology, 7(12), .
Chicago Style (17th ed.) CitationScagliotti, Giorgio V., and Christian Manegold. "Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study." Journal of Thoracic Oncology 7, no. 12 (2012).
MLA (9th ed.) CitationScagliotti, Giorgio V., and Christian Manegold. "Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study." Journal of Thoracic Oncology, vol. 7, no. 12, 2012.